Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04106843
Title Radioactive Drug (177Lu-DOTATATE) for the Treatment of Locally Advanced, Metastatic, or Unresectable Rare Endocrine Cancers
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

pituitary cancer

parathyroid carcinoma

thyroid gland medullary carcinoma

paraganglioma

pheochromocytoma

Therapies

lutetium Lu 177 dotatate

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.